Skip to main content
. Author manuscript; available in PMC: 2017 Jan 17.
Published in final edited form as: J Vasc Surg. 2010 May 14;52(1):5–12.e1. doi: 10.1016/j.jvs.2010.01.095

Table I.

Patient characteristics

Variablea All AAA repairs (N = 2386)
Elective
(N = 1959)
P valueb Symptomatic
(N = 156)
P valuec Ruptured
(N = 271)
Age, y 72 ± 8   .01d 74 ± 9   .856 74 ± 9  
Women, % 22   .035d 31   .001d 16
Smoking (prior or current), % 90   .213 86 >.99 85
Hypertension, % 82   .502 78   .860 81
Diabetes, % 18 >.99 17 >.99 15
Congestive heart failure, %   9   .019d 15   .751 12
COPD, % 37   .425 42 >.99 42
Creatinine ≥1.8 mg/dL, %   8   .393 10   .066 18
Previous CEA, %   6   .461   9   .479   6
Max AP AAA diameter, cm   5.8 ± 0.1 <.001d   6.6 ± 1.7 <.001d 7.1 ± 2.0
Preop medications, %
 Aspirin 71   .091 63   .001d 46
 Clopidogrel   5 >.99   6   .803   4
 Statin 62   .008d 51 <.001d 32
 β-blockers
 None 16   .378 14 <.001d 39
 Immediate preop 25 <.001d 43 <.001d 24
 Chronic 59 <.001d 44   .165 37
EVAR repair, % 48 <.001d 38 <.001d 12
Glasgow Aneurysm Score 79.4 ± 12 86.8 ± 15.8

AAA, Abdominal aortic aneurysm; AP, anteroposterior; CEA, carotid endarterectomy; COPD, chronic obstructive pulmonary disease.

a

Continuous variables are presented as mean ± standard deviation.

b

Elective vs symptomatic

c

symptomatic vs rupture; P value from F-test in analysis of variance for continuous variables and from χ2 test for categoric variables.

d

These values are significant (significant at level of .05).